ADVM - Adverum Biotechnologies GAAP EPS of -$0.33
2023-11-09 17:51:02 ET
More on Adverum Biotechnologies
- Adverum: H2 2023 Data Readouts For Wet-AMD Gene Therapy
- Adverum Biotechnologies appoints Andrew Ramelmeier as chief technology officer
- Seeking Alpha’s Quant Rating on Adverum Biotechnologies
For further details see:
Adverum Biotechnologies GAAP EPS of -$0.33